Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 218.00
+11.00 (5.31%)
Oct 26, 2026, 3:30 PM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 3.63 billion as of October 26, 2026. It is the 36,027th most valuable company in the world and the 3,345th biggest in Japan. Its market cap has increased by 7.39% in one year.
Market Cap
3.63B
Enterprise Value
4.03B
Revenue
13.64B
Global Rank
Country Rank
#3,345 Japan
PE Ratio
110.01
ChartMarket Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 3.63B, a decrease of -62.87%. That is a compound annual growth rate of -4.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 3.63B | -28.52% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.65B |
| BrightPath Biotherapeutics | 5.42B |
| Kringle Pharma | 5.00B |
| PRISM BioLab Co.,LTD | 4.92B |
| Kohjin Bio | 3.93B |
| Noile-Immune Biotech | 3.82B |
| Chordia Therapeutics | 3.79B |
| Ribomic | 3.68B |